Home Blog Science and Innovation strategy – another chance to add your views

Science and Innovation strategy – another chance to add your views

BIS has launched a survey seeking views on its science and innovation strategy

The Department for Business Innovation and Skills is working with partner organisations and other government departments to develop its next science and innovation strategy. The strategy will influence the future landscape in which charities will be funding and it is important for the government to hear lots from charities.

The strategy is due to be published with the autumn statement in 2014 alongside the ‘Science capital roadmap’ which will describe how the government will invest in science and research infrastructure from 2015 to 2021.

How has AMRC been involved?

AMRC is inputting into the strategy and road map in a number of ways:

  • We are sitting on the Ministerial Advisory Board representing charities
  • The APPG in Medical Research Summer Reception focused on calling for  long-term investment in medical research
  • We have submitted a response to the capital roadmap consultation
  • We have held a joint workshop with the Wellcome Trust and BIS for member charities to discuss the strategy
  • We have provided BIS with a written submission on what we think should be included in the strategy

What’s happening now? 

As part of the ongoing consultation, BIS is also seeking views via a Citizen Space website. This isn't a formal consultation or call for evidence in the traditional sense of the terms, but it is another opportunity to shape thinking and all input will be considered by the team drafting the strategy.

The web-portal will be open until 12 September 2014, but to have most impact, get your views in early.

We expect there will be other opportunities to influence and engage over the next months, so you can also send any views through to us to share. In this way, we can ensure that the UK continues to be an excellent place for research, and supportive environment for innovation and the adoption of new treatments for patients.